Cheon, HeeJin
Dziewulska, Karolina H.
Moosic, Katharine B.
Olson, Kristine C.
Gru, Alejandro A.
Feith, David J.
Loughran, Thomas P. Jr.
Article History
First Online: 15 February 2020
Compliance with Ethical Standards
:
: Thomas P. Loughran, Jr. is on the Scientific Advisory Board and has stock options for Keystone Nano and Bioniz Therapeutics. Thomas P. Loughran and David J. Feith have received honoraria from Kymera Therapeutics. There are no conflicts of interest with the work presented in this manuscript.